Januvia (sitagliptin) is a prescription drug that’s used to treat type 2 diabetes in adults. The drug comes as an oral tablet. It’s usually taken once per day. Januvia is used in adults to treat type ...

The Market Share for DPP-IV Inhibitors and GLP-1 Analogues Will Increase by 22 Percent Through 2019, According to Findings from Decision Resources BURLINGTON, Mass., Sept. 21 /PRNewswire/ -- Decision ...

(Reuters) - Merck and Co's diabetes drug Januvia achieved the main goal of a long-awaited heart safety study, according to preliminary results released by the drugmaker on Monday, likely removing a ...

April 18 (UPI) --In comparing three classes of medication for type 2 diabetes, researchers found one class, which includes the drugs Onglyza, Janumet and Januvia, did not reduce the risk of death.

Expert Rev Endocrinol Metab. 2008;3(6):691-697. Elimination of sitagliptin occurs primarily via renal excretion (79%) and involves active tubular secretion. Sitagliptin is a substrate for human ...

(Reuters) - Details of a large heart safety study presented on Monday appear to give Merck and Co's diabetes drug Januvia a clean bill of health, possibly setting the stage for a return to sales ...

Medicare Part D prescription drug plans generally cover prescription drugs like Januvia, which, along with diet and exercise, helps lower blood sugar for people with type 2 diabetes. The cost of ...

> The FDA's decision yesterday to require a new trial of Novartis' Galvus is seen as a big win for Merck, which is promoting its competing diabetes drug Januvia. Galvus is seen as a blockbuster drug ...

TRENTON, N.J. — U.S. regulators on Tuesday approved a new diabetes drug that reduces blood sugar levels and also helps people lose significant weight. Danish drugmaker Novo Nordisk said the Food and ...